OutSense Diagnostics
Toilet-based IoT Sensor for Detecting GI Conditions
Company Overview
Snapshot
Founded in January 2016 by Ishay Attar, OutSense Diagnostics operated with 11–50 employees. The company raised $4.75 million across 5 funding rounds from 4 investors. OutSense Diagnostics was acquired in November 2022.
Business overview
OutSense Diagnostics developed an IoT sensor for wellness monitoring and early detection of illness, primarily focusing on preventing colorectal cancer by identifying hidden blood in stool. Its core product is a clip-on toilet sensor that uses proprietary optical technology, data acquisition, and AI-powered computer vision algorithms to analyze human waste. The company served the healthcare market, targeting patients, providers, and seniors, and operated within the Digital Medical Diagnostics sector, offering solutions for various GI conditions, lifestyle monitoring, and personalized nutrition.
Strategic signal
In November 2022, OutSense Diagnostics was acquired, marking a significant exit for the company and its investors. This acquisition signals a validation of its innovative toilet-based IoT sensor technology for early disease detection and its potential to integrate into broader healthcare ecosystems, offering a new approach to continuous health monitoring.
Log in to access full profile ›Company Intelligence Q&A
- What is the primary focus of OutSense Diagnostics' technology?
- OutSense Diagnostics' technology primarily focuses on the early detection of colorectal cancer by identifying hidden blood in stool using a toilet-based IoT sensor. It also has applications for other GI conditions and wellness monitoring.
- When was OutSense Diagnostics acquired?
- OutSense Diagnostics was acquired in November 2022.
- Which investors participated in OutSense Diagnostics' Series A funding round in November 2020?
- In November 2020, OutSense Diagnostics secured Series A funding from Peregrine Ventures.
- What was a key partnership announced in June 2021?
- In June 2021, OutSense announced a partnership with CommuniCare Family of Companies to pilot its human waste detection technology.
- What was the purpose of the investment from Longevity Venture Partners in June 2021?
- The investment from Longevity Venture Partners in June 2021 was an extension of OutSense Diagnostics' Series A round, intended for product development and preparations for large-scale production.